Stock Events

Stock Events

Kancera AB 

€0.003800
0
+€0.00+0% Friday 06:00

Statistics

Day High
0
Day Low
0
52W High
0.1742
52W Low
0.0025
Volume
0
Avg. Volume
0
Mkt Cap
460,506.8
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22MayExpected
Q3 2024
Q1 2026
0.04
0.38
0.71
1.04
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-4.3MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Astrazeneca
AZN.ST
Mkt Cap2.59T
AstraZeneca operates in the biopharmaceutical sector, focusing on the discovery, development, and commercialization of prescription medicines, directly competing with Kancera's therapeutic areas.
Oncopeptides AB
ONCO.ST
Mkt Cap607.12M
Oncology Venture A/S focuses on the development of drugs for the treatment of cancer, making it a direct competitor to Kancera in the oncology research and development field.
Mendus AB
IMMU.ST
Mkt Cap378.73M
Immunicum AB develops immunotherapies for the treatment of cancer, competing with Kancera's cancer-focused research and therapies.
Xbrane Biopharma AB
XBRANE.ST
Mkt Cap222.54M
Xbrane Biopharma AB specializes in biosimilars and long-acting injectables, indirectly competing with Kancera by offering alternative cancer treatment solutions.

About

Novakand Pharma AB (publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase II study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. The company was formerly known as Kancera AB (publ) and changed its name to Novakand Pharma AB (publ) in September 2025. Novakand Pharma AB (publ) was incorporated in 2010 and is headquartered in Solna, Sweden.
Show more...
CEO
ISIN
SE0015658570
WKN
000A2QQQ4

Listings

MU
DE
3EE0.MU

0 Comments

Share your thoughts

FAQ

What is Kancera AB stock price today?▼
The current price of 3EE0.MU is €0.00 EUR — it has increased by +0% in the past 24 hours. Watch Kancera AB stock price performance more closely on the chart.
What is Kancera AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Kancera AB stocks are traded under the ticker 3EE0.MU.
What is Kancera AB market cap?▼
Today Kancera AB has the market capitalization of 460,506.8
What is Kancera AB revenue for the last year?▼
Kancera AB revenue for the last year amounts to 0 EUR.
What is Kancera AB net income for the last year?▼
3EE0.MU net income for the last year is -4.3M EUR.
In which sector is Kancera AB located?▼
Kancera AB operates in the Other sector.
When did Kancera AB complete a stock split?▼
Kancera AB has not had any recent stock splits.